CYP3A7*1C allele: linking premenopausal oestrone and progesterone levels with risk of hormone receptor-positive breast cancers

Abstract

Background

Epidemiological studies provide strong evidence for a role of endogenous sex hormones in the aetiology of breast cancer. The aim of this analysis was to identify genetic variants that are associated with urinary sex-hormone levels and breast cancer risk.

Methods

We carried out a genome-wide association study of urinary oestrone-3-glucuronide and pregnanediol-3-glucuronide levels in 560 premenopausal women, with additional analysis of progesterone levels in 298 premenopausal women. To test for the association with breast cancer risk, we carried out follow-up genotyping in 90,916 cases and 89,893 controls from the Breast Cancer Association Consortium. All women were of European ancestry.

Results

For pregnanediol-3-glucuronide, there were no genome-wide significant associations; for oestrone-3-glucuronide, we identified a single peak mapping to the CYP3A locus, annotated by rs45446698. The minor rs45446698-C allele was associated with lower oestrone-3-glucuronide (−49.2%, 95% CI −56.1% to −41.1%, P = 3.1 × 10–18); in follow-up analyses, rs45446698-C was also associated with lower progesterone (−26.7%, 95% CI −39.4% to −11.6%, P = 0.001) and reduced risk of oestrogen and progesterone receptor-positive breast cancer (OR = 0.86, 95% CI 0.82–0.91, P = 6.9 × 10–8).

Conclusions

The CYP3A7*1C allele is associated with reduced risk of hormone receptor-positive breast cancer possibly mediated via an effect on the metabolism of endogenous sex hormones in premenopausal women.

Metadata

Item Type:	Article
Authors/Creators:	Johnson, N Maguire, S Morra, A Kapoor, PM Tomczyk, K Jones, ME Schoemaker, MJ Gilham, C Bolla, MK Wang, Q Dennis, J Ahearn, TU Andrulis, IL Anton-Culver, H Antonenkova, NN Arndt, V Aronson, KJ Augustinsson, A Baynes, C Freeman, LEB Beckmann, MW Benitez, J Bermisheva, M Blomqvist, C Boeckx, B Bogdanova, NV Bojesen, SE Brauch, H Brenner, H Burwinkel, B Campa, D Canzian, F Castelao, JE Chanock, SJ Chenevix-Trench, G Clarke, CL Conroy, DM Couch, FJ Cox, A https://orcid.org/0000-0002-5138-1099 Cross, SS https://orcid.org/0000-0003-2044-1754 Czene, K Dörk, T Eliassen, AH Engel, C Evans, DG Fasching, PA Figueroa, J Floris, G Flyger, H Gago-Dominguez, M Gapstur, SM García-Closas, M Gaudet, MM Giles, GG Goldberg, MS González-Neira, A Guénel, P Hahnen, E Haiman, CA Håkansson, N Hall, P Hamann, U Harrington, PA Hart, SN Hooning, MJ Hopper, JL Howell, A Hunter, DJ Jager, A Jakubowska, A John, EM Kaaks, R Keeman, R Khusnutdinova, E Kitahara, CM Kosma, V-M Koutros, S Kraft, P Kristensen, VN Kurian, AW Lambrechts, D Le Marchand, L Linet, M Lubiński, J Mannermaa, A Manoukian, S Margolin, S Martens, JWM Mavroudis, D Mayes, R Meindl, A Milne, RL Neuhausen, SL Nevanlinna, H Newman, WG Nielsen, SF Nordestgaard, BG Obi, N Olshan, AF Olson, JE Olsson, H Orban, E Park-Simon, T-W Peterlongo, P Plaseska-Karanfilska, D Pylkäs, K Rennert, G Rennert, HS Ruddy, KJ Saloustros, E Sandler, DP Sawyer, EJ Schmutzler, RK Scott, C Shu, X-O Simard, J Smichkoska, S Sohn, C Southey, MC Spinelli, JJ Stone, J Tamimi, RM Taylor, JA Tollenaar, RAEM Tomlinson, I Troester, MA Truong, T Vachon, CM van Veen, EM Wang, SS Weinberg, CR Wendt, C Wildiers, H Winqvist, R Wolk, A Zheng, W Ziogas, A Dunning, AM Pharoah, PDP Easton, DF Howie, AF Peto, J dos-Santos-Silva, I Swerdlow, AJ Chang-Claude, J Schmidt, MK Orr, N Fletcher, O
Copyright, Publisher and Additional Information:	© The Author(s) 2021. Published by Springer Nature on behalf of Cancer Research UK. Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/.
Dates:	Accepted: 5 November 2020 Published (online): 26 January 2021 Published: 16 February 2021
Institution:	The University of Sheffield
Academic Units:	The University of Sheffield > Sheffield Teaching Hospitals
Funding Information:	Funder Grant number BREAST CANCER NOW TB2O19BAR
Depositing User:	Symplectic Sheffield
Date Deposited:	04 Mar 2021 17:29
Last Modified:	04 Mar 2021 17:29
Status:	Published
Publisher:	Springer Science and Business Media LLC
Refereed:	Yes
Identification Number:	10.1038/s41416-020-01185-w
Related URLs:	PubMed URL
Open Archives Initiative ID (OAI ID):	oai:eprints.whiterose.ac.uk:170952

Download

Published Version

Filename: s41416-020-01185-w.pdf

Licence: CC-BY 4.0

CLICK TO DOWNLOAD

CORE (COnnecting REpositories)

CYP3A7*1C allele: linking premenopausal oestrone and progesterone levels with risk of hormone receptor-positive breast cancers

Abstract

Metadata

Download

Published Version

Export

Statistics